David Hubacher, PhD, MPHSenior Epidemiologist
Areas of expertise
- Clinical research
- Intrauterine devices
- Subdermal implants
- Long-acting reversible contraception
- Clinical trials
- Health research
- Family planning
- Reproductive health
Projects & Resources
The goal of the Contraceptive Technology Innovation (CTI) Initiative is to develop new and strategically important contraceptives, through a strong focus on global partnerships, that ensures wide access to quality, affordable and acceptable products for those most in need.
FHI 360 developed and introduced innovative HIV prevention technologies — including microbicides and antiretrovirals — and worked with local partners to address the need for HIV prevention options, particularly for women.
This fact sheet summarizes the research agenda being implemented under the Contraceptive Technology Innovation (CTI) Initiative, a contraceptive research grant funded by the Bill & Melinda Gates Foundation.